Medical Breakthroughs
Outcomes-Per-Dollar: The Ultimate AI Investment Filter
In the burgeoning landscape of healthcare AI, where innovation often outpaces established evaluative frameworks, investors face…
Medical Breakthroughs
Preventative Care
Digital Health AI: The Billion Dollar Infrastructure of Value-Based Care
The landscape of value-based care (VBC) is undergoing a profound transformation, projected to reach a market…
Medical Breakthroughs
The Clinical Validation Multiplier: Boosting Healthcare AI Valuations
The valuation landscape for healthcare AI companies is increasingly bifurcated, separating those with robust, peer-reviewed clinical…
Medical Breakthroughs
AI Health Investments: Navigating Regulatory Risk for ROI
Navigating the labyrinthine regulatory landscape is arguably the most critical, yet often underestimated, dimension in assessing…
Preventative Care
Why HIPAA Compliance Is Health Plans’ AI Vendor Filter
For health plans and employers seeking to integrate artificial intelligence solutions, the promise of improved patient…
Chronic Conditions
Teladoc’s Billion Dollar Blunder: The Clinical Validation Gap
The $18.5 billion merger of Teladoc and Livongo in 2020 was heralded as a transformative moment…
Medical Breakthroughs
Olive AI: How a Billion-Dollar Valuation Evaporated Amidst an Evidence Gap
The trajectory of Olive AI, from a peak valuation of $4 billion to its eventual shutdown,…
Medical Breakthroughs
Babylon Health: The Billion Dollar Blunder in Digital Health
The implosion of Babylon Health, a digital health darling that once boasted a valuation of $4.2…
Medical Breakthroughs
Proteus Digital Health: The Ingestible Sensor’s Billion Dollar Blunder
The narrative of Proteus Digital Health serves as a stark reminder that even groundbreaking technological innovation,…
Medical Breakthroughs
Healthcare AI’s Billion Dollar Failures: The Investor’s Guide
The healthcare AI landscape, despite its transformative promise, is littered with cautionary tales of spectacular capital…